DekaBank Deutsche Girozentrale’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.4M | Hold |
746,287
| – | – | 0.06% | 251 |
|
|
2025
Q4 | $22.9M | Hold |
746,287
| – | – | 0.04% | 307 |
|
|
2025
Q3 | $26.1M | Hold |
746,287
| – | – | 0.04% | 288 |
|
|
2025
Q2 | $26.7M | Sell |
746,287
-3,057
| -0.4% | -$101K | 0.05% | 276 |
|
|
2025
Q1 | $22.8M | Buy |
749,344
+3,057
| +0.4% | +$96.9K | 0.04% | 291 |
|
|
2024
Q4 | $18.9M | Hold |
746,287
| – | – | 0.03% | 332 |
|
|
2024
Q3 | $20.8M | Buy |
746,287
+17,159
| +2% | +$475K | 0.04% | 319 |
|
|
2024
Q2 | $19.3M | Sell |
729,128
-20,216
| -3% | -$560K | 0.03% | 330 |
|
|
2024
Q1 | $22.5M | Buy |
749,344
+276,546
| +58% | +$8.15M | 0.04% | 302 |
|
|
2023
Q4 | $13.1M | Sell |
472,798
-6,826
| -1% | -$188K | 0.03% | 382 |
|
|
2023
Q3 | $13.2M | Buy |
479,624
+5,643
| +1% | +$168K | 0.03% | 373 |
|
|
2023
Q2 | $14.4M | Buy |
473,981
+15,334
| +3% | +$519K | 0.03% | 363 |
|
|
2023
Q1 | $16.2M | Sell |
458,647
-39,481
| -8% | -$1.46M | 0.04% | 323 |
|
|
2022
Q4 | $19.2M | Buy |
498,128
+216,827
| +77% | +$9.05M | 0.05% | 294 |
|
|
2022
Q3 | $11M | Buy |
281,301
+69,536
| +33% | +$2.97M | 0.03% | 356 |
|
|
2022
Q2 | $8.61M | Sell |
211,765
-1,587
| -0.7% | -$65.1K | 0.03% | 415 |
|
|
2022
Q1 | $8.52M | Buy |
213,352
+93,906
| +79% | +$3.69M | 0.02% | 451 |
|
|
2021
Q4 | $4.88M | Buy |
119,446
+9,619
| +9% | +$374K | 0.01% | 573 |
|
|
2021
Q3 | $3.97M | Sell |
109,827
-965
| -0.9% | -$37.5K | 0.01% | 587 |
|
|
2021
Q2 | $4.6M | Buy |
110,792
+2,698
| +2% | +$115K | 0.01% | 541 |
|
|
2021
Q1 | $4.62M | Buy |
108,094
+24,666
| +30% | +$1.17M | 0.02% | 503 |
|
|
2020
Q4 | $4.07M | Buy |
+83,428
| New | +$3.54M | 0.02% | 501 |
|
|
2020
Q3 | – | Sell |
-21,000
| Closed | -$1.02M | – | 1222 |
|
|
2020
Q2 | $1.02M | Buy |
+21,000
| New | +$1.04M | 0.01% | 651 |
|
Other funds holding RPRX
